DOI:
10.1055/s-00035331
Revista Urología Colombiana / Colombian Urology Journal
LinksClose Window
References
Mateo J, Porta N, Bianchini D. , et al.
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial.
Lancet Oncol 2020;
21 (01) 162-174
DOI: 10.1016/S1470-2045(19)30684-9 [Internet].
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.